Clarient Launches Gene Expression Test for Prostate Cancer

Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, announced the commercial launch of its new gene expression test for prostate cancer.
Yahoo! Finance